Ariel Investments, an investment management company, released its “Ariel Appreciation Fund" Q1 2026 Investor Letter. A copy ...
As of April 24 closing, the stock carries a strongly bullish consensus sentiment, receiving Buy ratings from all 14 analysts.
On April 2, Beam Therapeutics Inc. (NASDAQ:BEAM) released results from its Phase 1/2 BEACON study for ristoglogene ...
As of the April 24 closing, the stock carries a strongly bullish consensus sentiment. With a price target of $86.71, it ...
Back on March 30, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced clearance from the US Food & Drug Administration for ...
Denali Therapeutics Inc. (NASDAQ:DNLI) is one of the 10 best biotech stocks with highest upside potential. On April 6, Denali ...
The global gambling market has experienced steady growth over the past ten years, largely due to the shift to online platforms and mobile access. In fact, the online gaming section alone is expected ...
On April 13, William Blair maintained an Outperform rating on Ocular Therapeutix (NASDAQ:OCUL) right after the presentation ...
34m
Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide
As of the close of play on April 24, the broader consensus sentiments towards Praxis Precision Medicines Inc. (NASDAQ:PRAX) ...
The energy sector’s outperformance has been largely driven by ongoing conflict in the Middle East, which has choked around a ...
Furthermore, Viking is performing the Phase 3 VANQUISH-1 trial of VK2735 administered subcutaneously to patients for the ...
Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results